Program
All information is shown in the language in which it was submitted to ISPOR

Program Sunday, 17 September 2017

8:00 - 14:00
RESEARCH POSTER PRESENTATIONS - SESSION II
8:00 - 14:45
EXHIBIT/POSTER HALL HOURS (Nações Unidas, South Level)
8:00 - 16:00
SPEAKER READY ROOM HOURS (Caracas)
8:00 - 17:00
REGISTRATION HELP DESK HOURS (Grand Foyer)
8:30 - 9:30
BREAKOUT SESSION

8:30 - 9:30
Room: Comandatuba 2

IP7: RISK SHARING AGREEMENTS: PERSPECTIVES AND CHALLENGES FOR THEIR IMPLEMENTATION IN LATIN AMERICA: A MULTI-STAKEHOLDERS DEBATE

Presented in English and Spanish with simultaneous English/Portuguese/Spanish interpretation
Moderator:

Daniela Paredes Fernandez, BSc, RM, MPH, Assistant Professor, Departamento Promoción de la Salud de la Mujer y el Recién Nacido, Universidad de Chile, Santiago, Chile

Panelists:

Louis Garrison, PhD, Interim Director, PORPP, Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA, USA

Rony Lenz Alcayaga, MA, Profesor Asistente, Escuela de Salud Pública, Universidad de Chile y Consultor Principal, Lenz Consultores, Santiago, Chile

Diego F Guarin, MD, MPH, MA, Senior Director, HEOR & HTA Strategy, HEOR & HTA, Latin America, Merck-Serono, Billerica, MA, USA


8:30 - 9:30
Room: Comandatuba 1

IP8: EL CONCEPTO DE VALOR

Presented in Spanish
Moderator:

Diego Rosselli, MD, MEd, MHP, Profesor Adjunto, Economía de la Salud, Pontificia Universidad Javeriana, Bogotá, Colombia

Panelists:

Angela Chaves, DO, Presidente, Federación Colombiana de Enfermedades Raras, Bogotá, Colombia

Jaime Calderón, MD, Director Ejecutivo, Instituto de Evaluación Tecnológica en Salud, Bogotá, Colombia

Camila Quirland-Lazo, BSc, Investigadora, Escuela de Salud Pública, Unidad de Farmacoeconomía y Economía de la Salud, Universidad de Chile, Santiago, Chile


8:30 - 9:30
Room: Comandatuba 3
W6: EXPERIENCIA DE TRABAJO COLABORATIVO ENTRE PAISES DE AMÉRICA LATINA PARA LA TOMA DE DECISIONES INFORMADAS DE MEDICAMENTOS: PROYECTO DIME
Presented in Spanish
Discussion Leaders:

Claudia Vaca, MSc, Directora Tecnica Proyecto DIME/Profesor Asistente, Universidad Nacional de Colombia, Bogota, Colombia

Constanza Vargas, MSc, HTA Research Coordinator, Centro de Investigacion Clinica UC, Pontificia Universidad Catolica de Chile, Santiago, Chile

Rosa María Galindo-Suárez, MHE, Deputy General Director of Prioritization, General Health Council, Ministry of Health, Mexico City, Mexico

Ana Lucía Muñoz Mejía, Esp., Especialista Sénior de Protección Social, Proyecto Regional sobre Priorización y Planes de Beneficios en Salud, Banco Interamericano de Desarrollo, Bogotá, Colombia

Hernando Gaitán, MD, Professor, Departamento de Obstetricia y Ginecología, Universidad Nacional de Colombia, Bogota, Colombia


8:30 - 9:30
Room: São Paulo 3
W7: ARMONIZACIÓN DE ACTORES PARA LA INVESTIGACIÓN CENTRADA EN EL PACIENTE Y GENERACIÓN DE EVIDENCIA DEL MUNDO REAL PARA LA TOMA DE DECISIONES (Invited Workshop)
Discussion Leaders:

Pablo Otero, MD, Health Manager, Health Insurer, SURA, Bogotá, Colombia

Jaime Gonzalez, MD, MSc, Hematologist & Clinical Oncologist, Oncólogos de Occidente, Pereira, Colombia

Alejandro Bryón, MD, Project Manager, HEORT- Health Economics & Outcomes Research Team, Bogota, Colombia

Javier Garcia Perlaza, MD, MSc, Real World Evidence & Bone-Nephrology-Inflamation Medical Development Director, Amgen Intercontinental Region, Bogotá, Colombia


8:30 - 9:30
Room: Transamérica Auditorium
F2: DATOS Y EVIDENCIAS DEL MUNDO REAL EN LATINOAMÉRICA: ¿REALIDAD O FICCIÓN?
Presented in Spanish
Moderator:

Mariana Glancszpigel, Actuaria, Directora, 3Eff S.A., Buenos Aires, Argentina

Speakers:

Gerardo Machnicki, MSc, PhD, Director, Real World Evidence LATAM, Janssen, Buenos Aires, Argentina

Natalia Jorgensen, MSc, Advisor, Ministry of Health, Buenos Aires, Argentina

Federico Augustovski, MD, MSc, PhD, Director, Departamento de Evaluaciones Económicas y de Tecnologías Sanitarias, Instituto de Efectividad Clínica y Sanitaria (IECS), y Profesor de Salud Pública, Universidad de Buenos Aires, Buenos Aires, Argentina

Lizbeth Acuña Merchan, MSc, PhD(c), Directora Ejecutiva, Cuenta de Alto Costo, Fondo Colombiano de Enfermedades de Alto Costo, Bogotá, Colombia

9:30 - 10:00
BREAK, EXHIBITS & RESEARCH POSTER PRESENTATIONS VIEWING - SESSION II
10:00 - 12:00
WELCOME & SECOND PLENARY SESSION
WELCOME FROM THE ISPOR LATIN AMERICA CONSORTIUM CHAIR & PRESENTATION OF ISPOR SERVICE AWARDS
Speaker: Manuel Antonio Espinoza, MD, MSc, PhD
2016-2018 ISPOR Latin America Consortium Chair, Professor, Department of Public Health & Coordinator, HTA Unit, Center for Clinical Research, Catholic University of Chile, Santiago, Chile and Honorary Visiting Fellow, Centre for Health Economics, University of York, York, UK
2017 VALUE IN HEALTH REGIONAL ISSUES (LATIN AMERICA) EXCELLENT ARTICLE AWARD
AWARDEE: Ivan Mauricio Muñoz-Galindo, RN, MSc
National Director of Special Health Programs & Researcher, Salud Total EPS-S, Bogotá, Colombia
CONFERENCE RESEARCH PRESENTATION AWARDS
Presented by: Diego F. Guarín, MD, MPH, MA
Senior Director HEOR, Merck KGaA, Bogotá, Colombia
Presented by: Diego Rosselli, MSc, MEd, MD
Associate Professor of Health Economics, Epidemiology and Biostatistics Department Epidemiologia, Pontificia Universidad Javeriana, Bogotá, Colombia
REMARKS FROM ISPOR PRESIDENT-ELECT
Speaker: Federico Augustovski, MD, MSc, PhD
2017-2018 ISPOR President-Elect and Director, Health Technology Assessment and Health Economics Department of the Institute for Clinical Effectiveness and Health Policy (IECS-CONICET), Buenos Aires, Argentina
SECOND PLENARY SESSION: THE VOICE OF THE PATIENT: HEARING THEIR PERSPECTIVE AND INCORPORATING IN THE DECISION-MAKING PROCESS
Presented in English, Portuguese, and Spanish with simultaneous English/Portuguese/Spanish interpretation

Take Poll / Ask a Question→

The voice of the patient is often lost in the dialogue between health care stakeholders where providers, payers, government agencies, and manufacturers usually dominate the policy-making discussion in Latin America. In today’s world, the establishment of a number of patient groups has helped to amplify patients’ voices. This session will explore the challenges faced and opportunities available to more effectively bring the patient perspective into health care decision making.
Moderator: Federico Augustovski, MD, MSc, PhD
Director, Health Technology Assessment and Health Economics Department of the Institute for Clinical Effectiveness and Health Policy (IECS-CONICET), Buenos Aires, Argentina
Speaker: Eleanor Perfetto, RPh, PhD, MS
Senior Vice President, Strategic Initiatives, National Health Council, Washington, DC, USA
Speaker: Migdalia Denis, MA
President, Pulmonary Hypertension Society for Latin America, Board Member of International Alliance of Patient Organizations (IAPO), Miami, FL, USA
Speaker: Aline Silveira Silva, MS
Technologist at Executive Secretariat of the National Committee for Health Technology Incorporation – CONITEC, Brasilia, Brazil
12:00 - 14:45
LUNCH, EXHIBITS & RESEARCH POSTER PRESENTATIONS VIEWING - SESSION II
12:30 - 14:30
EDUCATIONAL SYMPOSIUM
12:30 - 14:30
Room: Comandatuba 2
VALUE AND PATIENT ACCESS TO SPECIALTY CARDIOVASCULAR DRUGS IN LATIN AMERICA
Presented in English, Portuguese, and Spanish with simultaneous English/Portuguese/Spanish interpretation

Symposium Description

(Sponsored by Amgen)

13:00 - 14:00
RESEARCH POSTER AUTHOR DISCUSSION HOUR - SESSION II
14:45 - 15:45
BREAKOUT SESSION

14:45 - 15:45
Room: Comandatuba 1

IP9: ANÁLISE DE DECISÃO MULTI-CRITÉRIOS (MCDA) NA AMÉRICA LATINA (Invited Issue Panel)

Presented in English and Portuguese
Moderator:

Joice Valentim, MSc DSc, Latin America HTA & Reimbursement Policy Lead, Roche Pharma, LA, São Paulo, Brazil

Panelists:

Martina Garau, Senior Economist, Office of Health Economics, London, UK

J. Jaime Caro, MDCM, FRCPC, FACP, Chief Scientist, Evidera, Waltham, MA, USA

Laura Murta Amaral, MSc, Project manager, SENSE Company, RJ, Brazil


14:45 - 15:45
Room: São Paulo 3

IP10: ESQUEMAS DE PRECIO BASADOS EN EL VALOR... ¿SEGURO QUE NO ES SUEÑO?

Presented in Spanish
Moderator:

Ramiro E. Gilardino, MD, MSc, Director, Global Networks Latin America, International Society for Pharmacoeconomics & Outcomes Research (ISPOR), Lawrenceville, NJ, USA

Panelists:

Lucas Najun Dubos, MD, MHE, Access Planning & HEOR Manager, Roche Argentina, Buenos Aires, Argentina

German De La llave, MD, Medical Head, ASE MEDIFE, Buenos Aires, Argentina

Diego Lencina, BS, Director, Azistia, Buenos Aires, Argentina


14:45 - 15:45
Room: Comandatuba 3

IP11: LIMIAR DE DISPOSIÇÃO A PAGAR NO BRASIL: POSSÍVEIS CAMINHOS

Presented in Portuguese
Moderator:

Everton Nunes Silva, PhD, Professor, Public Health, University of Brasilia, Brasília, Brazil

Panelists:

Rodrigo Antonini Ribeiro, MD, MSc, PhD, Managing Partner and Researcher, HTAnalyze and IATS, Porto Alegre, Brazil

Alexander Itria, researcher, HEAD, HEALTH ECONOMY, GOIAS UNIVERSITY, goiânia, Brazil

Carisi Anne Polanczyk, ScD, MD, Hospital de Clínicas de Porto Alegre and IATS, Porto Alegre, Brazil


14:45 - 15:45
Room: Transamérica Auditorium
W8: USO DE LA EVIDENCIA DEL MUNDO REAL (RWE) EN LA TOMA DE DECISIONES EN SALUD: LOS CASOS DE ARGENTINA, CHILE Y COLOMBIA
Presented in Spanish
Discussion Leaders:

Nahila Justo, MPhil MBA, Scientific Director, Mapi Sweden AB and Karolinska Institute, NVS department, Stockholm, Sweden

Manuel A. Espinoza, MD, MSc, PhD, Profesor, Departamento de Salud Pública y Jefe, Unidad de Evaluaciones de Tecnologías Sanitarias - Centro de Investigación Clínica, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile, e Investigador Visitante Honorario, Centro para la Economía de Salud, Universidad de York, York, UK

Diego Rosselli, MD, MEd, MHP, Profesor Adjunto, Economía de la Salud, Pontificia Universidad Javeriana, Bogotá, Colombia

Sebastian Garcia, MD, MSc, Coordinator, Departamento Evaluación de Tecnologías Sanitarias y Evaluaciones Económicas, IECS, Buenos Aires, Argentina


14:45 - 15:45
Room: Comandatuba 2
W9: RECENT EXPERIENCES USING THE EUROQOL EQ-5D INSTRUMENT IN LATIN AMERICA: THE 3L&5L; PUBLIC HEALTH AND ECONOMIC EVALUATIONS; NEWER TIME TRADE OFF VARIANTS AND DISCRETE CHOICE EXPERIMENTS
Presented in English and Spanish with simultaneous English/Portuguese/Spanish interpretation
Discussion Leaders:

Federico Augustovski, MD, MSc, PhD, Director, Departamento de Evaluaciones Económicas y de Tecnologías Sanitarias, Instituto de Efectividad Clínica y Sanitaria (IECS), y Profesor de Salud Pública, Universidad de Buenos Aires, Buenos Aires, Argentina

Henry H. Bailey, PhD, Lecturer, Arthur Lok Jack Graduate School of Business and the Centre for Health Economics, The University of the West Indies, Mt. Hope, Trinidad and Tobago

Victor Zarate, MD, MSc, PhD, Investigador, Departamento de Evaluación de Tecnologías Sanitarias, Ministerio de Salud de Chile, e Investigador, Escuela de Medicina, Universidad de los Andes, Santiago, Chile

15:45 - 16:00
BREAK
16:00 - 17:00
BREAKOUT SESSION

16:00 - 17:00
Room: Comandatuba 1

IP12: REAL WORLD STUDIES AND PUBLIC HEALTH POLICIES IN EMERGING MARKETS: NEEDS AND CHALLENGES

Presented in English
Moderator:

Otávio Augusto Camara Clark, MD, PhD, CEO, Evidencias - Kantar Health, Campinas, NJ, Brazil

Panelists:

Guilherme Silva Julian, PharmD, MSc, Clinical Research Specialist, Evidências - Kantar Health, São Paulo, Brazil

Diego Novick, MD, PhD, Research Advisor, Global Patient Outcomes and Real Wold Evidence, Eli Lilly and Company, Windlesham, Surrey, UK

Alexandre Dias Porto Chiavegatto Filho, B.Ec, PhD, Professor, Public Health, Universidade de São Paulo, São Paulo, Brazil


16:00 - 17:00
Room: São Paulo 3

IP13: O PAPEL DOS TESTES DIAGNÓSTICOS EM POLÍTICA PÚBLICA DE SAÚDE E EM DECISÕES CLÍNICAS: O ATUAL MODELO DE ATS É EFICIENTE?

Presented in Spanish and Portuguese
Moderator:

Charles V. Cachoeira, MD, MBA, Global Director Market Access, Roche Diagnostics, Tucson, AZ, USA

Panelists:

Murilo Contó, MBA, National Consultant of Health Technology Assessment and Management, PAHO/WHO, Brasília, Brazil

Esteban Lifschitz, MD, Director, Carrera de Médico Especialista en Evaluación de Tecnologías Sanitarias, Facultad de Medicina, Universidad de Buenos Aires (UBA), Buenos Aires, Argentina


16:00 - 17:00
Room: Comandatuba 3

IP14: NOVOS MODELOS DE REEMBOLSO NA SAÚDE: FOCO EM SAÚDE BASEADA EM VALOR (VALUE-BASED CARE)

Presented in Portuguese
Moderator:

Fernanda Maria Pirozelli Oliveira, Master in Management, Health Economics & Market Access Manager, Health Economics, Johnson & Johnson Medical Brazil, São Paulo, Brazil

Panelists:

Wilson Follador, PhD, MScD, PharmD, Managing Partner, TechValue Healthcare Consulting, São Paulo, Brazil

Cesar Luiz Lacerda Abicalaffe, MD, MS, CEO, 2iM Inteligência Medica S/A, Curitiba, Brazil

Marcelo Katz, MD, Senior Researcher, Value Management Office, Hospital Israelita Albert Einstein, Sao Paulo, Brazil


16:00 - 17:00
Room: Transamérica Auditorium
W10: HEALTH ECONOMICS AND OUTCOMES RESEARCH NEEDS ASSESSMENT FOR LATIN AMERICA: RELATIONSHIP BETWEEN PERCEIVED AND EXPECTED QUALITY OF KNOWLEDGE IN A SELF-ASSESSMENT SURVEY (Invited Workshop)
Presented in English
Discussion Leaders:

Andre Ferreira Azeredo-da-Silva, MD, PhD, Internal Medicine Physician, Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil

Iris Contreras, MD, MSc, Investigadora Asociada, Hospital General de Zona 1A Venados, Instituto Mexicano del Seguro Social, Mexico D.F., Mexico

Jeruza Lavanholi Neyeloff, MD, PhD, Epidemiologist, Hospital de Clínicas de Porto Alegre and IATS, Porto Alegre, Brazil


16:00 - 17:00
Room: Comandatuba 2
F3: ADAPTIVE PATHWAYS AND PATIENT ACCESS – IS THERE A PLACE FOR NEW PAYMENT MODELS?
Presented in English and Spanish with simultaneous English/Portuguese/Spanish interpretation
Moderator:

Marcelo Fonseca, MD, MSc, PhD, Professor, Federal University of São Paulo, São Paulo, Brazil

Speakers:

Rosa Maria Galindo Suarez, MHA, Deputy General Director of Prioritization, General Health Council, Mexico City, Mexico

Alarico Rodríguez, MD, Director Técnico Médico, Fondo Nacional de Recursos para la Medicina Altamente Especializada, Montevideo, Uruguay

Diego F Guarin, MD, MPH, MA, Senior Director, HEOR & HTA Strategy, HEOR & HTA, Latin America, Merck-Serono, Billerica, MA, USA

Finn Børlum Kristensen, MD, PhD, Professor, Faculty of Health Sciences, University of Southern Denmark, Hilleroed, Denmark bio

Contact ISPOR @ info@ispor.org | View Legal Disclaimer
© 2018 International Society for Pharmacoeconomics and Outcomes Research.
All rights reserved under International and Pan-American Copyright Conventions.